T1	Chemical	19 30	selumetinib
T2	Chemical	33 40	AZD6244
T3	Chemical	43 54	ARRY-142866
T4	Gene_or_protein	61 77	MEK1/2 inhibitor
T5	Chemical	59 79	a MEK1/2 inhibitor ,
T6	Chemical	83 112	combination with cetuximab in
T7	Disease	113 140	refractory solid tumors and
T8	Disease	146 172	mutant colorectal cancer .
R1	isEquivalentTo	Arg1:T1	Arg2:T2
R2	treats	Arg1:T1	Arg2:T6
R3	treats	Arg1:T1	Arg2:T7
R4	treats	Arg1:T1	Arg2:T8
R5	isEquivalentTo	Arg1:T2	Arg2:T1
R6	isEquivalentTo	Arg1:T2	Arg2:T3
R7	treats	Arg1:T2	Arg2:T6
R8	treats	Arg1:T2	Arg2:T7
R9	treats	Arg1:T2	Arg2:T8
R10	isEquivalentTo	Arg1:T3	Arg2:T1
R11	isEquivalentTo	Arg1:T3	Arg2:T2
R12	isEquivalentTo	Arg1:T3	Arg2:T4
R13	isEquivalentTo	Arg1:T3	Arg2:T5
R14	treats	Arg1:T3	Arg2:T7
R15	treats	Arg1:T3	Arg2:T8
R16	isEquivalentTo	Arg1:T4	Arg2:T1
R17	treats	Arg1:T4	Arg2:T6
R18	treats	Arg1:T4	Arg2:T7
R19	treats	Arg1:T4	Arg2:T8
R20	isEquivalentTo	Arg1:T5	Arg2:T1
R21	treats	Arg1:T5	Arg2:T6
R22	treats	Arg1:T5	Arg2:T7
R23	treats	Arg1:T5	Arg2:T8
R24	isEquivalentTo	Arg1:T6	Arg2:T1
R25	treats	Arg1:T6	Arg2:T7
R26	treats	Arg1:T6	Arg2:T8
R27	isEquivalentTo	Arg1:T7	Arg2:T1
R28	treats	Arg1:T7	Arg2:T8
R29	isAssociatedWith	Arg1:T8	Arg2:T2
R30	isAssociatedWith	Arg1:T8	Arg2:T3
R31	isAssociatedWith	Arg1:T8	Arg2:T4
R32	isAssociatedWith	Arg1:T8	Arg2:T5
R33	isAssociatedWith	Arg1:T8	Arg2:T6
